Primary effusion lymphoma
Primary Effusion Lymphoma[edit | edit source]
Primary Effusion Lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that is characterized by the presence of malignant lymphocytes in the body cavities without the formation of a solid tumor mass. It is most commonly associated with human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV).
Pathophysiology[edit | edit source]
PEL is primarily linked to infection with HHV-8, which is found in the tumor cells of nearly all cases. The virus is thought to play a crucial role in the transformation of normal lymphocytes into malignant cells. In addition to HHV-8, many patients with PEL are also co-infected with human immunodeficiency virus (HIV), which contributes to the immunocompromised state that allows for the development of this lymphoma.
Clinical Presentation[edit | edit source]
Patients with PEL typically present with symptoms related to the accumulation of fluid in the body cavities, such as the pleural cavity, peritoneal cavity, or pericardial cavity. Common symptoms include dyspnea, abdominal distension, and chest pain. Unlike other lymphomas, PEL does not usually form a solid tumor mass, and the diagnosis is often made by analyzing the fluid from the affected cavity.
Diagnosis[edit | edit source]
The diagnosis of PEL is made by cytological examination of the effusion fluid, which reveals large, atypical lymphoid cells. Immunophenotyping and molecular studies are used to confirm the presence of HHV-8 in the tumor cells. The cells typically express markers such as CD45 and CD30, but lack expression of B-cell markers like CD20.
Treatment[edit | edit source]
The treatment of PEL is challenging due to the aggressive nature of the disease and the frequent presence of co-morbid conditions such as HIV infection. Chemotherapy regimens similar to those used for other aggressive lymphomas, such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), are commonly employed. Antiretroviral therapy is also crucial for patients with HIV to improve immune function and control viral replication.
Prognosis[edit | edit source]
The prognosis for patients with PEL is generally poor, with a median survival of less than one year. Factors that influence prognosis include the patient's overall health, the presence of HIV infection, and the response to treatment.
Related Pages[edit | edit source]
Primary_effusion_lymphoma[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD